Expression and significance of SPARC, E-cadherin and EZH2 in endometrial carcinoma

Ting WANG,Lin-lei ZHAO,Xu ZHANG,Jun-fang HE
DOI: https://doi.org/10.3969/j.issn.1007-3434.2014.06.002
2014-01-01
Abstract:Objective To investigate the expression and clinical significance of SPARC, E-cadherin and EZH2 in endometrial carcinoma.Methods Evaluating the expression of SPARC, E-cadherin and EZH2 in normal endometrium, simple type hyperplasia, complex hyperplasia, atypical hyperplasia and endometrial carcinoma tissue by immunohistochemistry.Results ①The positive expres-sion rate of SPARC and E-cadherin in endometrial carcinoma tissue was significantly lower than that in normal endometrium, simple type hyperplasia, complex hyperplasia, atypical hyperplasia and endometrial carcinoma tissue( P<0.05);②The positive expression rate of EZH2 in endometrial carcinoma tissue was significantly higher than that in normal endometrium, simple type hyperplasia, complex hy-perplasia, atypical hyperplasia and endometrial carcinoma tissue(P<0.05);③The low expression of SPARC and E-cadherin was re-lated to the histopathological classification, operation-pathological stage, muscular layer infiltration depth and lymph node metastasis of endometrial carcinoma(P<0.05);④The high expression of EZH2 was related to the histopathological classification, operation-patho-logical stage and muscular layer infiltration depth of endometrial carcinoma(P<0.05), but not related to lymph node metastasis(P>0. 05) .Conclusion The down-regulated expression of SPARC and E-cadherin and up-regulated expression of EZH2 were related to the occurrence, development and prognosis of endometrial carcinomas.
What problem does this paper attempt to address?